Characterization of CDK9 role in the DNA damage response

被引：0
|
作者：
Nepomuceno, Thales C. [1 ]
Suarez-Kurtz, Guilherme [2 ]
Monteiro, Alvaro N. [1 ]
Carvalho, Marcelo A. [3 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] INCA, Rio De Janeiro, Brazil
[3] IFRJ, Rio De Janeiro, Brazil
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-1740
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1740
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Identification of a novel isoform of Cdk9
    Shore, SM
    Byers, SA
    Maury, W
    Price, DH
    GENE, 2003, 307 : 175 - 182
  • [22] CDK9 and mTOR: trading places
    Borden, Katherine L. B.
    BLOOD, 2019, 133 (11) : 1167 - 1168
  • [23] Identification of a novel CDK9 inhibitor targeting the intramolecular hidden cavity of CDK9 induced by Tat binding
    Asamitsu, Kaori
    Hirokawa, Takatsugu
    Okamoto, Takashi
    PLOS ONE, 2022, 17 (11):
  • [24] Role of cyclinT/Cdk9 complex in basal and regulated transcription (review)
    Napolitano, G
    Majello, B
    Lania, L
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2002, 21 (01) : 171 - 177
  • [25] BRCA1 recruitment to damaged DNA sites is dependent on CDK9
    Nepomuceno, Thales C.
    Fernandes, Vanessa C.
    Gomes, Thiago T.
    Carvalho, Renato S.
    Suarez-Kurtz, Guilherme
    Monteiro, Alvaro N.
    Carvalho, Marcelo A.
    CELL CYCLE, 2017, 16 (07) : 665 - 672
  • [26] The synthesis of PROTAC molecule and new target KAT6A identification of CDK9 inhibitor i CDK9
    Mingtao Ao
    Jun Wu
    Yin Cao
    Yaohui He
    Yuxiang Zhang
    Xiang Gao
    Yuhua Xue
    Meijuan Fang
    Zhen Wu
    Chinese Chemical Letters, 2023, 34 (04) : 248 - 253
  • [27] CDK9 inhibition activates innate immune response in prostate cancer cells
    Yalala, Shivani
    Gondane, Aishwarya
    Poulose, Ninu
    Liang, Jing
    Mills, Ian G.
    Itkonen, Harri M.
    CANCER RESEARCH, 2024, 84 (06)
  • [28] CDK9 inhibition activates innate immune response through viral mimicry
    Yalala, Shivani
    Gondane, Aishwarya
    Poulose, Ninu
    Liang, Jing
    Mills, Ian G.
    Itkonen, Harri M.
    FASEB JOURNAL, 2024, 38 (08):
  • [29] Pharmacodynamic biomarker strategies for CDK9 inhibition
    Matsumura, Yuta
    Tyagi, Ethika
    Whatcott, Clifford J.
    Foulks, Jason M.
    Siddiqui-Jain, Adam
    Bearss, David J.
    Warner, Steven L.
    CANCER RESEARCH, 2020, 80 (16)
  • [30] CDK9 inhibitors in acute myeloid leukemia
    Boffo, Silvia
    Damato, Angela
    Alfano, Luigi
    Giordano, Antonio
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
12345